BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 26805079)

  • 21. Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a case.
    Kinoshita S; Hirano A; Kobayashi S; Komine K; Kyoda S; Takeyama H; Uchida K; Morikawa T; Nagase J; Sakamoto G
    Breast Cancer; 2010; 17(1):71-4. PubMed ID: 19259764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of left breast cancer resulting in complete response by primary systemic therapy].
    Fukuda T; Watanabe T; Kawahara M; Kodama H; Kikuchi S; Suzuki H
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1497-500. PubMed ID: 17876155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study.
    von Minckwitz G; Rezai M; Loibl S; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Kühn T; du Bois A; Blohmer JU; Thomssen C; Dan Costa S; Jackisch C; Kaufmann M; Mehta K; Untch M
    J Clin Oncol; 2010 Apr; 28(12):2015-23. PubMed ID: 20308671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
    Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
    Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
    Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
    Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
    J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The case of a long-surviving patient with breast cancer and brain metastases treated using multidisciplinary therapy].
    Nishimura A; Nishi T; Morohashi S; Okano K; Hakamada K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1897-9. PubMed ID: 25731368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of paclitaxel and trastuzumab-resistant recurrent breast cancer with liver metastasis responding to S-1].
    Nomura T; Sonoo H; Miyake A; Souda M; Yamamoto Y; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Kurebayashi J
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1607-10. PubMed ID: 18799922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A Case of HER2-Positive Breast Cancer with Newly Diagnosed Stage IV That Responded to First-Line Pertuzumab and Trastuzumab-Based Therapy].
    Yoshioka S; Hojo S; Toyoda Y; Maeura Y
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1214-1216. PubMed ID: 29394585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A Case Report of Surgery and Chemotherapy for a Patient with Rapidly Progressing Breast Cancer during Pregnancy].
    Hazama Y; Nakai Y; Sugawara S; Nomura T; Matsumoto K; Matsumoto R; Sugihara M; Ishida T; Murata S; Murata T; Nakamura T; Moriya T; Kurebayashi J; Shimoya K
    Gan To Kagaku Ryoho; 2018 May; 45(5):847-850. PubMed ID: 30026449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of inflammatory breast cancer achieving pathological complete response by primary systemic therapy with CEF (cyclophosphamide, epirubicin, 5-fluorouracil) followed by docetaxel].
    Sagara Y; Rai Y; Sagara Y; Tamada S; Tsuchimochi S; Takahama T; Matsuyama Y; Ando M; Ooi Y; Sagara Y
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):77-80. PubMed ID: 17220675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response].
    Yoshida T; Horiguchi J; Koibuchi Y; Kanoh T; Iijima K; Yoshida M; Kikuchi M; Takata D; Oyama T; Iino Y; Morishita Y
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):907-10. PubMed ID: 15222110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case records of the Massachusetts General Hospital. Case 16-2012. A 32-year-old woman with HER2-positive breast cancer.
    Baselga J; Smith BL; Rafferty EA; Bombonati A
    N Engl J Med; 2012 May; 366(21):2018-26. PubMed ID: 22621630
    [No Abstract]   [Full Text] [Related]  

  • 34. [Two cases of breast cancer responding to primary systemic chemotherapy containing trastuzumab without surgery].
    Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):115-8. PubMed ID: 20087043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histologic grade of locally advanced infiltrating ductal carcinoma after treatment with induction chemotherapy.
    Frierson HF; Fechner RE
    Am J Clin Pathol; 1994 Aug; 102(2):154-7. PubMed ID: 8042581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Two Cases of Advanced HER2-Positive Locally Advanced Breast Cancer for Which Preoperative Chemotherapy with Pertuzumab, Trastuzumab, and Docetaxel Resulted in Good Response].
    Ishiyama T; Yamaya H; Jinguu A; Matsumoto H
    Gan To Kagaku Ryoho; 2020 Oct; 47(10):1505-1507. PubMed ID: 33130751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study.
    Untch M; Rezai M; Loibl S; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Kühn T; du Bois A; Blohmer JU; Thomssen C; Dan Costa S; Jackisch C; Kaufmann M; Mehta K; von Minckwitz G
    J Clin Oncol; 2010 Apr; 28(12):2024-31. PubMed ID: 20308670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients.
    Bellino R; Cortese P; Danese S; De Sanctis C; Durando A; Genta F; Grio R; Giardina G; Katsaros D; Massobrio M; Richiardi G; Vicelli R
    Anticancer Res; 2000; 20(6C):4825-8. PubMed ID: 11205227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of inflammatory breast cancer treated with preoperative intra-arterial infusion chemotherapy].
    Migita T; Shiiba K; Saito Y; Shibata C; Matsuno S
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2825-8. PubMed ID: 7993122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.